https://www.apollohealthco.com/wp-content/uploads/FacebookLiveManyAdvantages-of-New-High-Sensitivity-p-Tau-217-test2.jpg

In this Facebook Live Dr. Bredesen and Julie Gregory describe the advantages of BrainScan our new high-sensitivity p-Tau 217 test now available direct to a consumer without a prescription, as an alternative to painful and expensive tests.

BrainScan identifies three key biomarkers that give you a complete picture of your brain health. It will tell you if you abnormal levels of amyloid, neuronal damage, and/or ongoing inflammation.

The three biomarkers are:

p-Tau 217 – A specific biomarker for Alzheimer-related processes, which is both an early warning for avoiding dementia and for tracking disease progression and improvement.

NfL – A biomarker that tells us whether there is ongoing damage to our brain cells from vascular disease, head trauma, or any neurodegenerative process.

● GFAP – A biomarker of ongoing inflammation and repair in the brain. 

Dr. Bredesen and Julie G. describe those biomarkers during this Facebook Live session, and much more. Watch it in its entirety below.

Watch here:

Share This: